Version 2.77

Description

Approximately 75% of patients with neuromyelitis optica (NMO) express antibodies to the aquaporin-4 (AQP4) receptor. Diagnosis of NMO requires the presence of longitudinally extensive acute myelitis (lesions extending over 3 or more vertebral segments) and optic neuritis. While absence of antibodies to the AQP4 receptor does not rule out the diagnosis of NMO, presence of this antibody is diagnostic for NMO. Source: ARUP Laboratories, ARUP

Basic Part Properties

Part Display Name
Aquaporin 4 water channel Ab
Part Type
Component (Describes the core component or analyte measured)
Created On
2010-10-28

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP102618-8